V2X (VVX) has been awarded a position on the U.S. Navy’s Worldwide Expeditionary Multiple Award Contract 2.0, a key vehicle for delivering ...

Learn how about WEXMAC 2.0 aims to simplify procurement processes and improve logistical support for joint forces and federal agencies.

GM has joined PG&E’s vehicle-to-everything (V2X) pilot program, enabling energy customers to bundle their GM Energy systems and eventually get paid to supply excess energy back to their local grid.

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Nvidia (NVDA) CEO Jensen Huang took to the stage Tuesday afternoon to deliver his keynote speech at the chip giant's 2025 GTC event (GPU Technology Conference), where he previewed the company's ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

This was the stock's fourth consecutive day of gains.

After hours: March 17 at 6:04:08 PM EDT Loading Chart for VVX ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

After hours: March 14 at 5:52:47 p.m. EDT ...